google-site-verification: google28f501b00d980d5f.html Boehringer Ingelheim and Global Stem Cell Technology to bring ground-breaking innovation to equine market - Vetpol Community

Announcement

Collapse
No announcement yet.

Boehringer Ingelheim and Global Stem Cell Technology to bring ground-breaking innovation to equine market

Collapse
X
Collapse

  • Boehringer Ingelheim and Global Stem Cell Technology to bring ground-breaking innovation to equine market

    Click image for larger version

Name:	Boehringer.jpg
Views:	2
Size:	35.4 KB
ID:	48169
    The Boehringer Ingelheim Animal Health Business Unit and Global Stem Cell Technology (GST) entered into a partnership to enable European veterinarians and horse owners to benefit from ground-breaking innovation. Following marketing authorisation, Boehringer Ingelheim will exclusively distribute this highly innovative product in the EU. The product has been developed by GST and is the first-ever stem cell product in the veterinary world1 which was recommended marketing authorisation by the European Medicines Agency (EMA)1 earlier this year.

    Based on horse-blood-derived stem cells, which are specially primed, this medication is a candidate of the so-called novel therapies.

    Lameness is a common disease in horses and impacts their performance as well as welfare. Current treatment is not satisfactory for all cases and there is a clear need for innovation and new treatment options. Hence, the significant interest in treatment beyond symptoms, namely combatting the underlying root cause.

    “Priming the cells towards cartilage aids them to deliver the right activities in the affected joint,” shares Jan Spaas PhD, Veterinarian and CEO of GST. “We are absolutely delighted with this partnership as well as EMA´s positive opinion - the potential for the treatment is vast, since a quarter of the entire equine population develops osteoarthritis at some point in their life.”

    “Boehringer Ingelheim is dedicated to providing new and innovative products, whether through our own R&D activities or by working in partnership with true experts in the field,” says Dr. Erich Schoett, Head of Strategic Business Unit Equine at Boehringer Ingelheim. “GST impressed us with a wealth of expertise in the area of regenerative medicine and we do see an immense synergy in the close collaboration we are having. It is a real privilege to launch an industry first of this magnitude and we are working together closely to bringing this product to market.”

    1Press release issued by the European Medicines Agency on 22 June 2018: https://www.ema.europa.eu/en/news/fi...-authorisation
    Brought to you by Boehringer Ingelheim Animal Health UK Ltd.

    Further information available from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746960 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email:vetenquiries@boehringer-ingelheim.com. ©2019 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: Dec 2018 AHD11801. Use Medicines Responsibly.

    Boehringer Ingelheim
    Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
    Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
    As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
    More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

    Boehringer Ingelheim Animal Health Business Unit
    Boehringer Ingelheim is the second largest animal health business in the world. We are committed to creating animal wellbeing through our large portfolio of advanced, preventive healthcare products and services. With net sales of 3.9 billion euros (2017) and around 10,000 employees worldwide, we are present in more than 150 markets. For more information click here.

    Global Stem cell Technology NV
    GST is a privately owned company supported by Anacura and PMV. The main activities of GST are research and development and production of veterinary stem cell based products and their biotechnological applications. As a basis for stem cell therapies, GST uses highly potent stem cells from blood of mammals. GST thus translates regenerative medicine into clinical applications. The company was founded by veterinary stem cell researcher Jan H. Spaas (CEO) who is inventor of six patents and leading author on more than 25 scientifically peer-reviewed publications in this field. GST is globally ranked within the top 10 start-ups in animal health2. For more information, visit www.gst.be.

    2https://pages.agribusinessintelligence.informa.com/animal-pharm-disruptors-innovators-2018


      Posting comments is disabled.

    Categories

    Collapse

    Article Tags

    Collapse

    Latest Articles

    Collapse

    • Night RVN required at Grove Lodge Vets - Worthing, West Sussex
      IVC
      Come and join us at Grove Lodge Vets!

      Are you looking for an exciting new adventure within a growing company? Then look no further.
      We know there’s more to life than work – that’s why when you join Independent Vetcare Ltd at Grove Lodge Vets you’ll get your pick of our amazing company perks. That includes discounted shopping, discounted gym membership and great price cinema tickets, plus loads more.

      You’ll also get:

      • ECC Cert funded by practice...
      Today, 05:34 PM
    • RVN required at Budget Vets - Blackwood, Caerphilly
      IVC
      At Budget Vets, we are looking to add a vibrant nurse to our small and happy team in Blackwood. This is a thriving branch so we are looking for someone who is chatty and interactive with colleagues and clients alike and who isn’t afraid to muck in and use their initiative.

      We have excellent equipment and clinical level and are able to support an SVN coming in to the business if they are looking to complete their training.

      We place a lot of importance on work-life balance...
      Today, 02:36 PM
    • Vet required at Midforest Vets - Hampshire, UK
      IVC
      We have an exciting opportunity for a SA Vet, to join our well established dual site practice.

      Ideally, you will be 1+ years qualified, a great team player with a compassionate, confident and caring nature. We encourage clinical freedom, case independence, and case-continuity with an interesting and varied caseload.

      We offer;
      • Relocation package
      • 4 day week (40 hours)
      • 1 x Saturday in 5 with TOIL
      • 5 days CPD with budget of £1200 pa.
      •...
      Today, 09:57 AM
    • Mars Petcare Unveiled as New Diamond Partner for WSAVA
      Kristina Kisbee

      Mars Petcare has become a Diamond Partner of the World Small Animal Veterinary Association (WSAVA), building on a long-term relationship with the global veterinary association established by the Waltham Centre for Pet Nutrition, the company’s scientific HQ. Under the terms of the new partnership, individual divisions of Mars Petcare will support the work of four of the WSAVA’s key Clinical Committees as follows:

      · The Global Nutrition Committee (GNC), which helps the veterinary...
      Today, 08:42 AM
    • BCVSp Provides Clinical Audit Workshop for Specialists
      Kristina Kisbee


      The British College of Veterinary Specialists is running a clinical audit workshop to help members and non-members develop tools and strategy for clinical audit in Veterinary Specialist Practice. The one-day event will be held on 28 March 2019, at Rossdales Equine Hospital, Newmarket, Suffolk.


      The BCVSp is a registered charity, established in 2014. Its primary aim is to advance the education of the public and the wellbeing of animals through the development, understanding
      ...
      Today, 08:39 AM
    • Clinical Director required at Park View Vets - Lincoln
      IVC
      Are you wanting responsibility for making the key decisions on how a practice is run? Are you a motivated, enthusiastic vet with excellent clinical skills? Are you passionate about delivering excellent client and patient care?

      If so, an exciting opportunity awaits at Park View Veterinary Hospital in Lincoln. We require a new Clinical Director to join one other, and a large team of dedicated vets, nurses and receptionists. All the usual toys, purpose-built premises and not out of hours...
      Yesterday, 04:30 PM
    Working...
    X